The generation of antibodies is a hallmark of the fight against infection and is a principal goal in the design of vaccines. B lymphocytes produce distinct antibody isotypes by the process of class-switch recombination (CSR). Antibodies arising from the extrafollicular differentiation of B cells into antibody-secreting cells (ASCs) can prevent pathogen spread at early stages of infection, while switched antibodies quickly recruit effector cells during memory responses. Somatic hypermutation of the immunoglobulin-encoding genes increases antibody affinity. This requires the positive selection of B cells, bearing high-affinity membrane immunoglobulins, by T cells within germinal centers (GCs), the specific anatomical structures formed in peripheral lymphoid organs during many immune responses.
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Resting lymphocytes require glucose and glycolysis to survive but undergo metabolic reprogramming following antigen encounter to meet the energetic and biosynthetic demands of proliferation 1 . Unlike the activation of T cells, which results in a disproportionate increase in glycolysis, the activation of B cells via membrane immunoglobulins is accompanied by a balanced increase in both glycolysis and oxidative phosphorylation 2, 3 . The molecular mechanisms that control this metabolic reprogramming in lymphocytes have come under intense scrutiny and have highlighted a link between metabolic flux and cell-fate 'decisions' 1 .
The network of transcription factors required for the activation and subsequent differentiation of B cells has been elucidated in some detail 4, 5 . In contrast, despite the established role of splicing and polyadenylation in control of the expression of immunoglobulin-encoding genes, relatively little is known about how post-transcriptional regulation of gene expression influences the outcome of antigen encounter in B cells. The post-transcriptional fate of mRNA is mediated by its associated RNA-binding proteins (RBPs) and noncoding RNAs, which determine the timing and magnitude of protein expression 6, 7 . B cell-specific deletion of the RNA-processing enzyme Dicer inhibits the GC reaction 8 . Moreover, individual microRNAs, such as miR-155, are regulators of ASCs and GC formation [9] [10] [11] . Less is known about the importance of RBPs. Roquin is required for the restraint of helper T cell function during the GC reaction but has a minor role in B cells 12 . The RBP HNRNPD has been linked to B cell survival 13 , but essential functions for sequence-specific RBPs have not yet been found in B cells.
HuR (encoded by Elavl1 ('embryonic lethal, abnormal vision-like 1')) is an RBP linked to both the nuclear regulation and the cytoplasmic regulation of RNA fate. HuR binds to uridine tracts present mostly within introns and 3′ untranslated regions, which correlates with its function as regulator of the splicing and stability of mRNA 14, 15 . Mice with homozygous deficiency in HuR die in utero 16 . Mice with conditional deletion of HuR have proven a useful tool with which to understand the role of HuR in myeloid cells, where it limits 4 1 6 VOLUME 16 NUMBER 4 APRIL 2015 nature immunology A r t i c l e s proinflammatory cytokine production during chronic inflammation and cancer 17, 18 . HuR is required for the maintenance of hematopoietic stem cells 19 and the selection and chemotaxis of T cells 20 .
Here we found that regulation of the B cell transcriptome by HuR was essential for normal antibody responses. B cell-specific deletion of HuR revealed an obligatory role for HuR in the GC reaction. Moreover, the production of class-switched antibodies induced by thymusindependent antigens was dependent on HuR. To identify the direct targets of HuR action, we mapped HuR-RNA interactions at the singlenucleotide level of resolution in primary B cells 21, 22 . The integration of gene-expression profiling by high-throughput mRNA sequencing (mRNA-seq) and the identification of translationally regulated mRNA by ribosomal profiling (or 'footprinting') (ribo-seq) established a direct correlation between changes in gene expression and in the translation of specific mRNAs bound by HuR. Our analysis indicated that HuR regulated the expression of genes encoding molecules related to energy metabolism in B cells and prevented the accumulation of fatal levels of reactive oxygen species (ROS) upon the activation of B cells.
RESULTS

Increased HuR expression upon B cell activation
We found that HuR was the only member of the Elavl family of RBPs expressed in splenic B cells (Fig. 1a) . To understand the role of HuR during B cell development and activation, we generated mice with conditional, B cell-specific deletion of loxP-flanked Elavl1 alleles (Elavl1 fl/fl ) by Cre recombinase expressed from the B cell-specific gene Mb1 (Mb1-Cre) (called 'HuR-cKO' mice here). Elavl1 +/+ Mb1-Cre mice served as a control (except where noted otherwise). Analysis of HuR expression by flow cytometry showed that in HuR-cKO mice, it was absent from the pro-B cell stage in the bone marrow (BM) and was undetectable in transitional and mature B lymphocytes (Fig. 1b-d) . HuR was expressed similarly in all B cell populations present in the spleen (Fig. 1c,d ). Quantitative RT-PCR analysis of GC B cells formed in the spleen of wild-type (C57BL/6) mice after immunization with the hapten NP (4-hydroxy-3 nitrophenylacetyl) coupled to keyhole limpet hemocyanin (KLH) showed a sixfold greater abundance of Elavl1 mRNA in GC B cells than in non-GC B cells (Fig. 1e) . Intracellular flow cytometry indicated that HuR protein was twofold more abundant in GC B cells than in non-GC B cells (Fig. 1f) . In vitro activation of B cells with lipopolysaccharide (LPS) or with antibody to the costimulatory receptor CD40 (anti-CD40) plus interleukin 4 (IL-4) and IL-5 increased the expression of HuR protein by up to threefold relative to its expression in unstimulated B cells (Fig. 1g) . Together these data suggested that HuR expression increased during B cell activation in vitro and in vivo.
B cell development following deletion of HuR in pro-B cells
Normal proportions of B cell subpopulations were present in the BM, spleen and lymph nodes of HuR-cKO mice (Fig. 2a-c slightly fewer pre-B cells in the BM and transitional and follicular B cells in the spleen of HuR-cKO mice than in that of control mice ( Fig. 2a-c) . HuR-cKO mice had fewer B-1 cells in the peritoneal cavity than the control mice had (Fig. 2d) . Analysis of incorporation of the thymidine analog BrdU (2-bromodeoxyuridine) into the DNA of rapidly proliferating pre-B cells was not different in HuR-cKO mice than in the control mice ( Fig. 2e and Supplementary Fig. 1a) . Furthermore, B cell turnover in the spleen, inferred from incorporation of BrdU over a 7-day period, was not different in HuR-cKO mice than in control mice ( Fig. 2f and Supplementary Fig. 1b ). Thus, with the exception of B-1 cells, there was little requirement for HuR for either B cell development or homeostasis.
B cells require HuR for normal antibody responses
HuR-cKO mice had significantly lower titers of immunoglobulins of all isotypes in the serum, apart from IgA, than did control mice (Fig. 3a) .
The titers of immunoglobulin G1 (IgG1) and IgG2b were 2.5-fold lower in HuR-cKO mice than in control mice, whereas the titers of IgG3 and IgM were 6-and 12-fold lower, respectively. The lower IgM titers could have resulted from the lower abundance of B-1 cells, as these contribute substantially to serum IgM. The biggest difference was in IgG2c titers, which were 200-fold lower in HuR-cKO mice than in control mice. The decrease in almost all antibody isotypes was probably reflective of a requirement for HuR in B cells for a functional response following an encounter with antigen.
To investigate the requirement for HuR during the response of B cells to antigen, we immunized control and HuR-cKO mice with the thymus-independent antigens Ficoll or LPS coupled to the hapten NP. NP-reactive IgM titers in serum were fivefold lower in HuR-cKO mice than in control mice in response to either antigen (Fig. 3b,c) . We were unable to detect NP-reactive IgG3 antibodies in serum from HuR-cKO mice, in contrast to their detection in control mice (Fig. 3b,c) . Next (Fig. 3d) . Titers of NP 23 -reactive IgG1 (where 'NP 23 ' indicates 23 moieties of NP conjugated to LPS or Ficoll), which reflect the combination of both low-affinity antibodies and high-affinity antibodies, were 15-fold lower in HuR-cKO mice than in control mice (Fig. 3d) . Memory responses, evaluated 7 d after secondary immunization, were clearly detectable in HuR-cKO mice in the form of IgM (Fig. 3d) . In contrast, NP 2 -reactive IgG1 titers did not increase in the HuR-cKO mice (Fig. 3d) , which suggested that memory cells expressing highaffinity IgG1 did not form or, if they did, their reactivation failed to generate ASCs. As a measure of affinity maturation, we determined the ratio of NP 2 -reactive IgG1 to NP 23 -reactive IgG1; these results indicated that NP-reactive antibodies in HuR-cKO mice failed to undergo affinity maturation (Fig. 3e) . Affinity maturation takes place in GCs, where helper T cells select B cells with the highest affinity for antigen. GC formation at 7 d after immunization with NP-KLH was diminished in HuR-cKO mice relative to that in control mice (Fig. 3f) . The number of GC B cells was more than sixfold lower in HuR-cKO mice than in control mice (Fig. 3f) . Similarly, following administration of highly immunogenic sheep red blood cells, the GC response was defective over time in HuR-cKO mice ( Supplementary Fig. 1c,d) . Consistent with the diminished titers of serum antibodies, the number of NP-reactive IgM + ASCs was twofold lower in the spleen of HuR-cKO mice immunized with NP-KLH than in that of control mice immunized in the same way, whereas the number of NP-reactive IgG1 + ASCs was 50-fold lower in HuR-cKO mice than in control mice (Fig. 3g) . We found a similar lower number of NP-reactive IgM + and IgG1 + ASCs in the spleen of HuR-cKO mice than in that of control mice at 7 d after secondary immunization with NP-KLH (Fig. 3h) . Further analysis of ASCs in the BM showed that HuR-cKO mice and control mice contained a similar number of NP-reactive IgM + ASCs, but NP-reactive IgG1 + ASC were barely detectable in HuR-cKO mice (>100-fold fewer than in control mice) (Fig. 3i) . These data showed that HuR was required for proper activation and/or differentiation of B cells following antigen encounter.
Regulation of the B cell transcriptome by HuR
To determine whether an early stage of B cell activation was affected by the absence of HuR, we measured changes in intracellular Ca 2+ following crosslinking of cell surface IgM. The Ca 2+ flux elicited after activation of B cells with either a highly crosslinking antibody to IgM F(ab′) 2 or a monoclonal antibody (B7.6) to IgM was similar for B cells from the lymph nodes of HuR-cKO mice and those of control mice ( Supplementary Fig. 2a) . Additionally, surface expression of CD40, the cytokine receptor CD25 (IL-2Rα), the activation marker CD69 and the costimulatory molecule CD86 (B7-2) was increased to a similar extent on cells from control and HuR-cKO mice in response to a variety of stimuli ( Supplementary Fig. 2b,c) , which indicated that at least by these criteria, B cell activation was normal in the absence of HuR.
To identify the molecular mechanisms regulated by HuR in freshly isolated splenic B cells (called 'ex vivo' B cells here) and in splenic B cells activated in vitro with LPS, we performed an integrated analysis of three high-throughput measurements of the B cell transcriptome. First, we searched for differences in mRNA expression in B cells from HuR-cKO mice relative to mRNA expression in B cells from control . Together these measurements have the power to identify changes in RNA isoforms and RNA abundance, as well as changes in translational regulation, and can be used to relate such changes to HuR binding. Thus, the changes detected could be ascribed to direct or indirect effects of HuR-RNA interactions. None of the changes were due to compensatory regulatory mechanisms that affected the abundance or ribosome loading of mRNAs encoding other members of the Elavl family or of other AU-rich element-binding proteins (Supplementary Fig. 3) .
Analysis of differences in expression by mRNA-seq and ribo-seq followed by pathway-enrichment analysis showed enrichment for gene signatures related to various aspects of the cell cycle and energy metabolism in HuR-cKO B cells, relative to their abundance in control B cells ( Table 1) . HuR deficiency influenced the expression of genes encoding molecules related to glycolysis, the tricarboxylic acid (TCA) cycle and oxidative phosphorylation, three pathways in which the expression of these genes was higher both in GC B cells and after activation of B cells with LPS than in naive B cells (Supplementary Fig. 4a-c) . Blockade of these energy pathways through the use of 2-deoxyglucose, the inhibitor CPI-613 (which inhibits pyruvate dehydrogenase and 2-oxoglutarate dehydrogenase (α-KGDH)) or oligomycin A decreased the survival, growth and proliferation of B cells after stimulation with mitogen ( Supplementary Fig. 4d,e) . Analysis of the global mRNA expression and translation of genes related to glycolysis, the TCA cycle and oxidative phosphorylation showed no difference in these parameters in ex vivo control B cells versus ex vivo HuR-cKO B cells ( Supplementary  Fig. 4f ). In contrast, global mRNA expression and translation of these genes were higher in LPS-activated HuR-cKO B cells than in LPSactivated control B cells (Supplementary Fig. 4f ), which suggested that HuR was important for regulating the reprogramming of energy metabolism only after activation of the cells. Correlation of data from mRNA-seq and ribo-seq for only those metabolism-related genes translated differently in LPS-activated HuR-cKO B cells than in LPSactivated control cells showed that all of these, with the exception of Dlst, which encodes dihydrolipoamide S-succinyltransferase (DLST), had modestly increased expression and/or translation in control B cells relative to their expression and/or translation in HuR-cKO B cells ( Fig. 4a and Supplementary Fig. 4g,h,j) . The abundance of Dlst mRNA was greater in GC B cells than in naive B cells ( Supplementary  Fig. 4i ), but the expression and translation of Dlst mRNA was significantly lower in LPS-activated B cells from HuR-cKO mice than in LPS-activated B cells from Elavl1 fl/fl Mb1 +/+ mice (Fig. 4b) . 
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DLST is one of the three subunits of the α-KGDH enzymatic complex, which is essential for maintaining TCA-cycle flux and cell-energy supply. To understand the role of HuR in regulating Dlst mRNA, we examined mRNA-seq data and plotted the reads mapped across the Dlst locus. These mRNA-splicing profiles showed that a single mRNA transcript was generated after RNA splicing in ex vivo and LPSactivated Elavl1 fl/fl Mb1 +/+ B cells (Fig. 4c) . In the absence of HuR, Dlst mRNA showed two alternative splicing events: retention of intron 10, and alternative inclusion of a cryptic exon between exons 10 and 11 (Fig. 4c) . The iCLIP data showed that HuR bound to several locations along Dlst RNA (Fig. 4c and Supplementary Fig. 5a-c) . Peakcalling analysis showed that HuR 'preferentially' bound to introns, including the poly-pyrimidine tract downstream of the 3′ splice site of the cryptic exon present within intron 10 ( Supplementary Fig. 5d ). Together these data demonstrated that the binding of HuR to Dlst pre-mRNA might promote the expression and translation of Dlst mRNA in HuR-cKO B cells. The modest change in translation of other components of cell energy pathways might have reflected a compensatory mechanism.
Binding of HuR to introns modulates alternative intron use
To gain mechanistic insight into the role of HuR in mRNA splicing in B cells, we further examined the HuR iCLIP data obtained with LPSactivated B cells. Analysis of unique read counts in all three iCLIP experiments showed that 75% of HuR-RNA crosslink sites mapped to introns (Fig. 5a and Supplementary Fig. 5e,f) . Visualization of HuR crosslink sites near the exon-intron boundaries indicated that HuR 'preferentially' bound to introns and mostly bound between the branch point and the 3′ splice site (Fig. 5b) . These data suggested that HuR might be a splicing regulator in B cells; thus, we investigated whether HuR modulates the splicing of pre-mRNA by further analysis of mRNA-seq data obtained with LPS-activated B cells. Analysis of differences in exon use did not reveal substantial differences in exon levels for protein-coding transcripts in the absence of HuR and failed to identify the alternative splicing events associated with Dlst mRNA (Supplementary Tables 1-5 ). Thus, we performed an 'introncentric' analysis of the mRNA-seq data (Supplementary Fig. 6a) , which showed that 530 introns belonging to 375 genes were used differently in LPS-activated HuR-cKO B cells than in control B cells A r t i c l e s (adjusted P value, <0.1; Supplementary Fig. 6b ). HuR was bound to 85% of these 375 genes in at least two of the three independent HuR iCLIP experiments (Fig. 5c) . Dlst was among these genes. Together, the correlation of data from the 'intron-centric' analysis and HuR iCLIP experiments identified alternative intron use in the absence of HuR.
HuR modulates mRNA expression and translation via splicing
Analysis of all 375 genes identified above with different intron use in HuR-cKO B cells versus control B cells (group 1) showed no global change in the expression and translation of these genes in the absence of HuR (Supplementary Fig. 6c) . Individually, 64 of those 375 genes were expressed differently in LPS-activated HuR-cKO B cells than in LPS-activated Elavl1 fl/fl Mb1 +/+ B cells and their mRNAs were bound to HuR (group 2) (Fig. 5d) . A similar data correlation showed that 71 of the 375 genes were both translated differently in LPS-activated HuR-cKO B cells than in LPS-activated Elavl1 fl/fl Mb1 +/+ B cells and the mRNA bound to HuR (group 3) (Fig. 5e) . Only 25 of those 71 genes were both expressed differently and translated differently in HuR-cKO B cells than in Elavl1 fl/fl Mb1 +/+ B cells (group 4) (Fig. 5f ).
When we analyzed the expression of genes in groups 1, 2 and 3 globally, we observed no differences in mRNA abundance in HuR-cKO B cells versus Elavl1 fl/fl Mb1 +/+ B cells (Fig. 5g) . In contrast, global translation of these mRNAs was significantly lower in HuR-cKO B cells than in Elavl1 fl/fl Mb1 +/+ B cells (Fig. 5h) , which suggested that even though HuR-dependent regulation of alternative splicing might not necessarily affect the overall level of mRNA, HuR was required for mRNA translation. Global expression and global translation of the genes in group 4 were both up to 50% lower in HuR-cKO B cells than in Elavl1 fl/fl Mb1 +/+ B cells (Fig. 5h) . Closer examination of individual genes indicated that both mRNA expression and mRNA translation of 76% of the genes in group 4 (19 of 25), including Dlst, were lower in the absence of HuR (Fig. 5i,j) . In summary, analysis of differences in intron use and its correlation with differences in expression as analyzed by mRNA-seq and ribo-seq allowed us to discover the alternative intron events associated with the binding of HuR. Visualization of read coverage revealed high complexity in mRNA splicing associated with the 25 genes in group 4 and detected up to eight different alternative splicing events associated with Slc25a19 (which encodes the mitochondrial thiamine pyrophosphate carrier TPC) in the absence of HuR (Supplementary Fig. 6d,e) . Genetic deletion of either Dlst or Slc25a19 has been associated with diminished α-KGDH enzymatic activity and alterations in the TCA cycle 23, 24 .
HuR regulates splicing of Dlst mRNA
To understand the role of HuR in mRNA splicing, we selected Dlst mRNA for detailed analysis and evaluated the use of intron 10 by two RT-PCR assays. HuR-cKO B cells showed more intron retention than did Elavl1 fl/fl Mb1 +/+ B cells (Fig. 6a) . Read-coverage analysis of the Dlst locus with mRNA-seq data from HuR-cKO B cells identified a previously unknown alternative exon-splicing site located after exon 10 ( Fig. 4c) . This alternative exon 10b was previously annotated in Ensembl as the start exon of predicted transcript ENSMUST00000165575; however, evidence of the existence of this transcript is lacking. The detection of reads mapped across the exon 10-alternative exon 10b junction suggested that this was an alternative exon inclusion rather than an alternative first exon. RT-PCR confirmed that conclusion and indicated that over 50% of Dlst transcripts in HuR-cKO B cells included the alternatively spliced 
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A r t i c l e s exon 10b (Fig. 6b) . mRNA-seq data showed little change in Dlst mRNA expression in the absence of HuR in ex vivo or LPS-activated B cells (Fig. 6c) . However, HuR-cKO B cells had twofold fewer ribosome 'footprints' mapped to Dlst mRNA than did Elavl1 fl/fl Mb1 +/+ B cells (Fig. 6d) , indicative of less mRNA translation. Visualization of ribosome footprints as 'sashimi plots' failed to identify ribosome-protected reads that mapped to the alternative exon 10b ( Supplementary  Fig. 7a ), which suggested that transcripts containing this exon were not translated. Consistent with that finding, inclusion of alternative exon 10b introduced several stop codons into the coding sequence (Supplementary Fig. 7b ). Immunoblot analysis of extracts of ex vivo and LPS-activated B cells confirmed a 50% lower abundance of DLST in HuR-deficient B cells than in Elavl1 fl/fl Mb1 +/+ B cells (Fig. 6e,f) . Antibodies reactive with the amino terminus of DLST did not detect any alternative protein isoforms produced as a consequence of insertion of exon 10b into Dlst in the absence of HuR ( Supplementary  Fig. 7c ). Decreased expression of DLST protein was associated with lower α-KGDH enzymatic activity in HuR-cKO B cells than in Elavl1 fl/fl Mb1 +/+ B cells (Fig. 6g) . Thus, binding of HuR to Dlst intron 10 prevented the inclusion of an alternative exon and thus guaranteed translation of Dlst mRNA into an enzymatically active protein.
B cell proliferation and immunoglobulin CSR require α-KGDH DLST, as part of the α-KGDH complex, is highly regulated so flux through the TCA cycle can be maintained. Inhibition of the α-KGDH enzymatic activity through the use of α-KG analogs (succinyl phosphonate (SP) or phosphonoethyl ester of succinyl phosphonate (PESP)) significantly reduced B cell viability (Fig. 7a) . Analysis of B cell proliferation after stimulation with LPS and IL-4 showed that inhibition of α-KGDH reduced proliferation in a dose-dependent manner (Fig. 7b,e) . Further analysis of CSR showed that the number of IgG1 + cells was significantly reduced not only after chemical inhibition of α-KGDH enzymatic activity but also among B cells with a single copy of Dlst (Dlst +/− B cells) (Fig. 7c,d) . Thus, α-KGDH enzymatic activity was required for the survival, proliferation and CSR of B cells in vitro.
ROS scavengers 'rescue' B cell proliferation and CSR Analysis of B cell cultures showed that cell viability was reduced in the absence of HuR (Fig. 8a,b) . The viability of HuR-cKO B cells was not restored by blockade of caspase-dependent apoptosis or programmed necrosis through the use of the caspase inhibitor Q-VD-OPh or necrostatin-1, respectively, but was restored by the H 2 O 2 scavenger catalase (Fig. 8b,c) . Consistent with those results, fluorescence of the ROS reporter dye H 2 DCFDA showed that viable HuR-cKO B cells produced more ROS than did control B cells (Fig. 8b) . The addition of catalase diminished H 2 DCFDA fluorescence (Fig. 8b) , indicative of lower ROS concentration. HuR-cKO B cells failed to proliferate when cultured with mitogens in vitro (Fig. 8d and Supplementary Fig. 8) . Supplementation of the medium with catalase as well as with ROS scavengers such as sodium pyruvate, N-acetyl cysteine or EUK134 enhanced the proliferation of HuR-cKO B cells in response to a variety of stimuli ( Fig. 8d and Supplementary Fig. 8) . Quantification of the B cells recovered showed that HuR-cKO B cells and control B cells underwent a similar number of cell divisions; however, there were fewer HuR-cKO cells in each division (Fig. 8e) , which indicated that the ROS scavengers did not completely restore proliferation. The addition of ROS scavengers led to a recovery in the frequency and number of IgG1 + and CD138 + (ASC) HuR-cKO B cells (Fig. 8f,g ). However, NAC and EUK134 marginally inhibited the yield of IgG1 + and CD138 + cells in cultures of control B cells (Fig. 8f,g ). Together our data indicated that HuR-cKO B cells contained elevated amounts of ROS and these compromised B cell survival. Mitigating ROS allowed the HuR-cKO B cells to proliferate, undergo CSR and form ASCs in vitro.
DISCUSSION
Here we found that HuR was dispensable for B cell development but that the GC response and the production of class-switched antibodies following immunization with thymus-independent antigens was highly dependent upon HuR. Our in vitro experiments indicated that HuR might control cell metabolism upon B cell activation to limit ROS production, but further confirmation in the context of the GC response is required.
The regulation of intracellular ROS is important during the activation of lymphocytes 25 . A greater abundance of ROS is found in activated B cells from virus-infected mice 26 . B cells deficient in the voltage-gated proton channel HVCN1 produce a lower abundance of ROS and have attenuated antibody responses 27 , and the administration of antioxidants to mice increases B cell apoptosis and decreases B cell proliferation 26 . However, lack of ROS production in mice deficient in the gp91 phox subunit of the NADPH oxidase complex has been linked to modestly increased responses to T cell-independent type 2 antigens 28 . Thus, a general picture is emerging for B cells in which ROS production can be separated in space and time. Low levels of ROS have mitogenic properties, whereas high levels will induce cell death 29, 30 . H 2 O 2 produced by NAPDH oxidases after crosslinking of the B cell antigen receptor (BCR) exerts a short-lived function as an inhibitor of tyrosine and lipid phosphatases 31 and thus enhances signal transduction. BCR-associated ROS production early after antigen encounter may not be essential for B cell proliferation; however, mitochondria-mediated ROS production is needed to sustain BCR-mediated activation 28, 32 . Interestingly, in vitro exposure to H 2 O 2 can revive signaling via the BCR on GC B cells 33 . One proposed mechanism involves enhancement of the kinase PI(3)K-metabolic checkpoint kinase complex mTORC axis for metabolic reprogramming after activation of lymphocytes 34, 35 . Our global transcriptome analysis comparing naive B cells versus GC B cells and ex vivo B cells versus LPS-stimulated B cells reinforced the published observations that both glycolysis and oxidative phosphorylation are increased after B cell activation 2, 36 as part of a metabolic program that takes place in both GC B cells 37 and in vitro-stimulated B cells to promote survival and proliferation and in which post-transcriptional regulation by HuR is a critical component.
The presence of hydroxyl radicals also enhances the deamination of cytosine to uracil, a reaction that is necessary for CSR 38 . CSR requires control of ROS levels by DNA damage-sensing proteins such as p53 A r t i c l e s and Atm. p53 limits ROS production in B cells and promotes switching to IgG2a 39 . Atm expression during the repair of double-stranded DNA breaks decreases ROS levels via the regulation of cell energy pathways. Atm −/− mice have an impaired antibody response and elevated ROS that is restored by treatment with the antioxidant N-acetyll-cysteine 40 . Furthermore, the Atm-specific inhibitor KU-55933 decreases cellular ATP levels by diminishing TCA cycle intermediates and oxidative respiration 41 . Thus, we suggest that diminished energy metabolism during CSR might limit progression through the cell cycle and might prevent the accumulation of ROS until double-stranded DNA breaks are repaired. By sustaining the TCA cycle, HuR ensures provision of the reducing equivalents required for ATP synthesis and/or ROS scavenging. Evidence has accumulated demonstrating that increased glycolysis is part of a metabolic switch during activation of cells of the immune system 1 . Although the TCA cycle is the main provider of reducing equivalents for oxidative phosphorylation, its regulation during lymphocyte activation remains largely unexplored. We used CPI-613 to inhibit PDH and α-KGDH, two key enzymes of the TCA cycle; this resulted in a block in the growth and proliferation of B cells. It has been reported that CPI-613 induces an oxidative burst responsible for inhibition of the enzymatic activity of α-KGDH 42 . This observation underscores the importance of regulating ROS production during B cell activation and is strengthened by our finding that phosphonate analogs of α-KG 43 The α-KGDH complex has three subunits: α-oxoglutarate dehydrogenase (encoded by Ogdh), DLST (encoded by Dlst), and dihydrolipoamide dehydrogenase (encoded by Dld). Dlst is a haploinsufficient gene, and Dlst +/− mice show increased ROS production and cell death in the brain 44 . The APP670/671 mutation of DLST in humans diminishes enzyme activity and causes Alzheimer's disease associated with mitochondrial dysfunction and cell death 45 . Decreased DLST diminishes the provision of reducing equivalents and succinyl-CoA required for GTP synthesis by matrix-substrate-level phosphorylation 46 . Increased ROS levels in the absence of HuR may be due to increased translation of mRNA from genes encoding components of the oxidative respiratory chain, but diminished matrix-substrate-level phosphorylation may additionally contribute to ROS production by increasing ADP levels 47 . Furthermore, α-KGDH activity generates • O 2 − , which acts as a negative regulator of α-KGDH enzymatic activity 48, 49 . Thus, oxidative stress may promote cell death due to inhibition of flux through the TCA cycle 50 .
Our approach of integrating global analysis of the expression and translation of mRNA comparing control and HuR-cKO primary B cells has revealed a role for HuR in the regulation of metabolism after B cell activation. We applied a bioinformatics approach to identify differences in intron use based on read counting within intron 'bins' defined as windows between annotated exons. We identified 530 introns from 375 genes that were expressed differently in the absence of HuR. HuR loss was associated with aberrant intron inclusion that compromised, for Dlst, the abundance and translation of mRNA but might also affect the isoform of translated proteins. Quantitative analysis of full-length transcripts and alternative protein isoforms in the presence and absence of HuR should address this. We suggest that HuR, like other splicing regulators, promotes the correct splicing of pre-mRNA and provides a quality-control mechanism for the transcriptome. In the context of B cell activation, depletion of HuR promotes an imbalance in energy metabolism that led to the fatal accumulation of ROS and impaired B cell proliferation and CSR.
METHODS
Methods and any associated references are available in the online version of the paper.
Accession codes. GEO: mRNA-seq, GSE62129; ribo-seq, GSE62134; iCLIP, GSE62148. 24 . Mice were immunized by intraperitoneal administration of sheep red blood cells (2 × 10 8 per mouse), NP-Ficoll (25 µg), NP-LPS (25 µg) or alum-precipitated NP-KLH (100 µg). For in vivo experiments, the number of animals was decided on the basis of preliminary studies with small cohorts to assess the magnitude of the changes (two to three mice per genotype). Six to ten mice (12-16 weeks of age) were considered a sufficient number of mice in final studies to reach sufficient statistical power analysis. No animals were excluded due to a lack of responsiveness to immunization. Randomization, but not experimental 'blinding' to sample identity, was used for these studies. 
Enzyme-linked immunosorbent and enzyme-linked immunospot assay.
Serum immunoglobulins and NP-specific antibodies were detected by enzymelinked immunosorbent assay 52 . NP-specific antibody endpoint titers were used as a measure of relative concentration. NP-specific ASCs were detected by enzyme-linked immunospot assay as described 9 .
Flow cytometry. B cell populations were analyzed with anti-B220, anti-CD19, anti-CD21, anti-CD23, anti-CD25, anti-c-kit, anti-CD138, anti-CD93, antiIgG1, anti-IgD, anti-IgM, anti-CD95, anti-CD40, anti-CD69, anti-GL7 and anti-CD86 (Supplementary Table 7 B cell isolation and cell culture. B cells from spleen or peripheral lymph nodes were isolated with a B Cell Isolation Kit from Miltenyi Biotec. B cells were cultured in RPMI-1640 medium (Dutch Modification) plus 5% FCS, antibiotics, 2 mM l-glutamine and β-mercaptoethanol (50 µM). ROS scavengers, Q-VD-OPh, necrostatin-1, 2-deoxy-glucose, CPI-613, oligomycin A, SP and PESP were added to the cell culture medium as needed. Mitogen activation of B cells was achieved with LPS (Escherichia coli strain 0127:B8, Sigma Aldrich), anti-CD40 (3/23; purified in-house) or anti-IgM (B7.6; purified in-house) in the presence or absence of recombinant mouse IL-4 (Peprotech) and IL-5 (Sigma Aldrich).
Protein separation and immunoblot analysis. Total cell extracts were prepared by incubation of cells in RIPA buffer (50 mM Tris-HCl, pH 7.4, 150 mM NaCl, 1% NP-40, 0.1% SDS and 0.5% sodium deoxycholate) supplemented with protease inhibitors. 10% polyacrylamide-SDS gels were loaded with 20 µg of total protein extract per lane. Gel electrophoresis and protein transfer to nitrocellulose membranes was performed before detection of HuR, DLST and β-actin by immunoblot analysis with mouse monoclonal anti-HuR, rabbit monoclonal anti-DLST or rabbit polyclonal anti-DLST and mouse monoclonal anti-β-actin (Supplementary Table 7 ) and visualization by enhanced chemiluminescence or IRDye detection at 694 or 794 nm.
RNA extraction and RT-PCR assays. Total RNA was extracted from purified B cells with TRIzol (LifeTech). 1 µg of RNA was treated with DNase I before reverse transcription into cDNA. Dlst alternative splicing events were analyzed by RT-PCR with specific primers (Supplementary Table 3) . Intron retention was assessed by quantitative PCR, whereas alternative exon inclusion was quantified after gel densitometry of the PCR products. Quantitative PCR assays were performed with Platinum SYBR Green qPCR SuperMix (Life Technologies). Expression of mRNA from Dlst and Elavl was quantified by the comparative threshold cycle (∆∆C T ) method and results were normalized to the expression of 18S rRNA.
iCLIP. iCLIP experiments were performed as described 21 with lysates of splenic B cells obtained from C57BL/6 mice and activated in vitro for 48 h with LPS. Splenic B cells were irradiated with ultraviolet light for crosslinkage of protein-RNA (150 mJ/cm 2 ; Stratalinker 2400). After washing of cells with ice-cold PBS, total cell extracts were obtained with RIPA buffer and sonication (three times). Extract supernatants were treated for 3 min at 37 °C with RNase I (0.167 U/ml). HuR-RNA complexes were immunoprecipitated using 2 µg mouse monoclonal anti-HuR (Supplementary Table 8) coupled to protein G Dynabeads. Extracts of HuR-cKO B cells were used as a negative control. After washing of samples twice with high-salt buffer (50 mM Tris-HCl, pH 7.4, 1 M NaCl, 1 mM EDTA, 1% NP-40, 0.1% SDS and 0.5% sodium deoxycholate) and once with PNK washing buffer (20 mM Tris-HCl, pH 7.4, 10 mM MgCl 2 and 0.2% Tween-20), one tenth of each sample was labeled with [ 32 P]ATP with PNK, whereas an RNA linker was ligated to the rest of the sample after dephosphorylation of RNA. RNA-protein complexes were separated by SDS-PAGE and were transferred to nitrocellulose membranes. HuR-RNA complexes with a molecular size above 55 kilodaltons were isolated after visualization by autoradiography. RNA was extracted by incubation of the nitrocellulose fragment for 10 min at 37 °C with proteinase K in PK buffer (100 mM Tris-HCl, pH 7.5, 50 mM NaCl and 10 mM EDTA). 200 µl of PK buffer containing urea (7 M) was added to each sample, followed by further incubation for 20 min at 37 °C. RNA was isolated by phenol-chloroform extraction and ethanol precipitation. RNA was retro-transcribed into cDNA with RCLIP primers (Supplementary Table 9 ) and SuperScript III reverse transcriptase. After purification of cDNA with 6% TBE-urea gels, cDNA was circularized and amplified by PCR with Solexa P5/P7 primers. cDNA libraries were thus prepared and analyzed. RCLIP primers included a seven-base-long 'barcode' at the 5′ end (three known bases plus four unknown nucleotides). An additional two bases (AT) were added to the 3′ end. These 'barcodes' allowed us to 'multiplex' different cDNA libraries for Illumina sequencing and identify PCR duplicate reads.
High-throughput sequencing and library preparation. mRNA-seq libraries were obtained with a TruSeq Stranded mRNA Sample Prep Kit (Illumina). Splenic B cells from individual control or HuR-cKO mice were independently processed for RNA extraction (ex vivo samples) or were stimulated for 48 h with LPS in RPMI medium plus 1 mM sodium pyruvate.
Published mRNA-seq libraries were used for analysis of the expression of genes encoding molecules involved in glycolysis, the TCA cycle and electron transport in naive and GC B cells (GEO accession code GSE47705) 53 .
Ribosomal profiling ('footprinting') (ribo-seq) assays were performed with an ARTseq Ribosome Profiling Kit (Epicentre, Illumina). Ex vivo or LPSactivated B cells were treated with cycloheximide (100 µg/ml) 3 min before the preparation of cell extracts.
cDNA libraries were sequenced with either GAIIX (iCLIP) or HTSeq2000 (mRNA-seq and ribo-seq) Illumina technology. The type of sequencing performed was as follows: iCLIP, 40 bp, single end; mRNA-seq, 100 bp, single end; and ribo-seq, 50 bp, single end.
